Research Analysts’ updated eps estimates for Monday, September 24th:

Leerink Swann began coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO). The firm issued a market perform rating on the stock.

ASSA ABLOY AB/S (OTCMKTS:ASAZY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Assa Abloy AB offers locks and security products. Its product offer include mechanical locks such as door locks and cylinder locks and security doors, electromechanical locks, electronic locks, door closers, door automatics, access control systems. Assa Abloy also provides secure identity solutions, contactless identification technology solutions, electronic lock systems and safes for hotels and cruise ships. The Company primarily sells in Europe and in North America. Assa Abloy AB is based in Stockholm, Sweden. “

Altisource Portfolio Solutions (NASDAQ:ASPS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Altisource Portfolio Solutions S.A., together with its subsidiaries, is engaged in provision of real estate mortgage portfolio management and related technology products, as well as asset recovery and customer relationship management services. The Company has three segments: Mortgage Services, Financial Services and Technology Products. Mortgage Services provides valuation, real estate sales, default processing services, property inspection and preservation services, homeowner outreach, closing and title services and knowledge process outsourcing services. Financial Services comprises the Company’s asset recovery management and customer relationship management offerings to the financial services, consumer products, telecommunications and utilities industries. Technology Products is engaged in the design, development and delivery of technology products and services to the mortgage industry. “

Grupo Aeroportuario dl Srst SAB CV (NYSE:ASR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Grupo Aeroportuario del Sureste is a Mexican airport operator with concessions to operate, maintain and develop the airports of Cancun, Merida, Cozumel, Villahermosa, Oaxaca, Veracruz, Huatulco, Tapachula and Minatitlan in the southeast of Mexico. “

Alexco Resource (NYSEAMERICAN:AXU) (TSE:AXR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Alexco Resource Corp. is a precious metals exploration company with a silver focus and a growing environmental services business. The Company conducts mineral exploration in Canada, primarily in Yukon, and performs reclamation and remediation services at mine sites using its rights to certain patents and the expertise acquired by its officers. “

Alteryx (NYSE:AYX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Alteryx, Inc. provides self-service data analytics software platform. The Company’s product consists of Alteryx Designer, Alteryx Server and Alteryx Analytics Gallery. Alteryx Designer offer data preparation, blending and analytics which could be deployable in the cloud and on premise; Alteryx Server, a secure and scalable product for sharing and running analytic applications in a Web-based environment and Alteryx Analytics Gallery, a cloud-based collaboration offering which allows users to share workflows in a centralized repository. Alteryx, Inc. is headquartered in Irvine, California. “

Allianz (OTCMKTS:AZSEY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $25.00 target price on the stock. According to Zacks, “Allianz AG’s principal activities are carried out through four divisions: Life/Health: Provides any of life and heath insurances; Property/Casualty: Provides property and casualty insurance, travel insurance and credit insurance; Banking: Provides a range of banking services, including lending, deposit taking, investment banking; Asset Management: Asset Management for third party investor and Asset under Management which cover the owners investments. “

Leerink Swann assumed coverage on shares of Beigene (NASDAQ:BGNE). The firm issued an outperform rating on the stock.

Biocept (NASDAQ:BIOC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California. “

Bryn Mawr Bank (NASDAQ:BMTC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “The Bryn Mawr Bank Corporation is a bank holding company. “

Bank of Commerce (NASDAQ:BOCH) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Bank of Commerce Holdings is a financial service holding company that owns Redding Bank of Commerce, Roseville Bank of Commerce, a division of Redding Bank of Commerce and Bank of Commerce Mortgage, an affiliate of Redding Bank of Commerce and Roseville Bank of Commerce. “

Chesapeake Energy (NYSE:CHK) was downgraded by analysts at SunTrust Banks, Inc. from a buy rating to a hold rating.

Leerink Swann started coverage on shares of Clovis Oncology (NASDAQ:CLVS). They issued a market perform rating on the stock.

Concho Resources (NYSE:CXO) was upgraded by analysts at SunTrust Banks, Inc. from a hold rating to a buy rating.

Leerink Swann assumed coverage on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH). Leerink Swann issued an underperform rating on the stock.

Quest Diagnostics (NYSE:DGX) had its target price raised by Credit Suisse Group AG from $121.00 to $128.00. The firm currently has an outperform rating on the stock.

Leerink Swann assumed coverage on shares of Epizyme (NASDAQ:EPZM). They issued a market perform rating on the stock.

Leerink Swann assumed coverage on shares of Incyte (NASDAQ:INCY). They issued a market perform rating on the stock.

JD.Com (NASDAQ:JD) had its target price reduced by MKM Partners to $41.00. They currently have a buy rating on the stock.

Leerink Swann initiated coverage on shares of Loxo Oncology (NASDAQ:LOXO). They issued an outperform rating on the stock.

Matador Resources (NYSE:MTDR) was downgraded by analysts at SunTrust Banks, Inc. from a buy rating to a hold rating.

SilverBow Resources (NYSE:SBOW) was downgraded by analysts at SunTrust Banks, Inc. from a buy rating to a hold rating.

First Analysis started coverage on shares of SendGrid (NYSE:SEND). They issued a strong-buy rating on the stock.

Leerink Swann began coverage on shares of Seattle Genetics (NASDAQ:SGEN). Leerink Swann issued an outperform rating on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its target price lowered by Needham & Company LLC to $196.00. The firm currently has a buy rating on the stock.

Leerink Swann started coverage on shares of TESARO (NASDAQ:TSRO). The firm issued an outperform rating on the stock.

Receive News & Ratings for Agios Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agios Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.